Septerna (SEPN) Interest & Investment Income (2023 - 2026)
Septerna's (SEPN) quarterly Interest & Investment Income came in at $5.0 million in Q1 2026, up 12.75% year-on-year from $4.5 million in Q1 2025, and down 5.75% quarter-over-quarter from $5.3 million in Q4 2025.
Septerna (SEPN) Interest & Investment Income (2023 - 2026) Analysis & Trends
Septerna's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 12.75% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $20.1 million, a 70.33% increase from a year earlier, with the FY2025 full-year figure at $19.5 million, up 126.65% from the prior year.
- Interest & Investment Income retreated to $5.0 million in Q1 2026 per SEPN's latest filing, from $5.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.6 million in Q3 2025 and bottomed at $1.1 million in Q3 2023.
- The 4-year median for Interest & Investment Income is $3.9 million (2024), against an average of $3.2 million.
- Across the five-year window, Interest & Investment Income surged 248.87% in 2025 and rose 12.75% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $1.3 million in 2023, then jumped by 211.39% to $3.9 million in 2024, then soared by 36.59% to $5.3 million in 2025, then decreased by 5.75% to $5.0 million in 2026.
- Per Business Quant, the three latest SEPN Interest & Investment Income figures stand at $5.0 million (Q1 2026), $5.3 million (Q4 2025), and $5.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Septerna | 1.51 Bn | 1.51 Bn | - | 5.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.03 Mn |
| Dec 31, 2025 | 5.34 Mn |
| Sep 30, 2025 | 5.57 Mn |
| Jun 30, 2025 | 4.17 Mn |
| Mar 31, 2025 | 4.46 Mn |
| Dec 31, 2024 | 3.91 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.10 Mn |